2SHB 2145: Protecting patient access to discounted medications and health care services through Washington's health care safety net by preventing manufacturer limitations on the 340B drug pricing program.
Did not pass. The 2025-26 session has ended.
- Sponsor
- Thai
- Introduced
- January 12, 2026
- Status
- H Rules R
- Last action
- Referred to Rules 2 Review. (February 9, 2026)
- As of
- October 16, 2026, 5:15 AM Pacific, from the Legislature’s records
What this bill does
Prohibits a manufacturer or a distributor or third-party logistics provider of a manufacturer's drugs from restricting the acquisition of drugs under the 340B Drug Pricing Program (340B Program). Prohibits a manufacturer or a distributor or third-party logistics provider of a manufacturer's drugs from requiring a 340B Program covered entity to submit data as a condition for allowing the acquisition of drugs under the 340B Program.
From the Washington State Legislature's nonpartisan staff bill analysis. Read the full analysis ↗
Track 2SHB 2145 on OlympiaTrack
A free account adds the full hearing and amendment record, who testified, roll calls by member, and a list to track it on. Paid plans add a plain-English AI summary and an alert if its subject comes back next session.
Create a free accountOther bills sponsored by Thai
- 2SHB 1207: Concerning superior court clerk fees.
- 2SHB 1359: Reviewing laws related to criminal insanity and competency to stand trial.
- 2SHB 1614: Modifying the capital gains tax.
- E3SHB 1634: Providing school districts and public schools with assistance to coordinate comprehensive behavioral health supports for students.
- ESHB 1718: Concerning well-being programs for certain health care professionals.
All 2025-26 Washington State bills →
Source: the Washington State Legislature. OlympiaTrack is an independent bill-tracking service and is not affiliated with the Legislature. View on leg.wa.gov ↗